Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Wanglin Bio-Tech Co., Ltd. is a specialized biotechnology and pharmaceutical company based in Jiangshan, China, focused on the production of high-purity plant-based carbon and charcoal products. Established in 2014, the company is recognized as the first certified professional producer of vegetable carbon black (E153) in China and operates a GMP-certified facility. Its product portfolio includes pharmaceutical-grade medicinal charcoal tablets, activated coconut charcoal, and various botanical powders used in the pharmaceutical, food, and cosmetic industries. Through its subsidiary, Wanglin (Wuhan) Pharmaceutical Co., Ltd., the company provides medicinal-grade products for detoxification and gastrointestinal health. Wanglin serves a global market, exporting to the US, EU, and Asia, and holds numerous international quality and safety certifications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wanglin.